ClinConnect ClinConnect Logo
Search / Trial NCT06831045

Bikini vs Longitudinal Incision in Direct Anterior Approach (DAA) Total Hip Arthroplasty (THA)

Launched by UNIVERSITY OF MIAMI · Feb 13, 2025

Trial Information

Current as of November 13, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at two different types of cuts (or incisions) made during a specific type of hip surgery called Direct Anterior Approach Total Hip Arthroplasty (THA). The goal is to find out if one type of incision leads to better healing of the wound and higher satisfaction for patients compared to the other type. If you are between the ages of 65 and 74, have a body mass index (BMI) of 30 or more, and are scheduled for a hip replacement surgery, you may be eligible to participate in this study.

Participants in this trial will receive one of the two incision types during their surgery and will be monitored for how well their wounds heal and how satisfied they feel with their surgery results. It's important to note that individuals with a lower BMI, those who have had previous surgery on the same hip, or those who cannot have spinal anesthesia will not be included. This study aims to improve surgical techniques and outcomes for future hip replacement patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with body mass index greater than or equal to 30
  • Patients undergoing primary unilateral DAA THA
  • Patients undergoing primary THA
  • Exclusion Criteria:
  • Patients with body mass index less than 30
  • Patients with a history of prior open surgery on the affected hip
  • Patients unable/unwilling to undergo spinal anesthesia under monitored anesthesia care (MAC)
  • Patients with allergies or absolute contraindication to standardized drugs administered within the University of Miami protocol for total hip replacement
  • The following groups will not be included: adults unable to consent, individuals who are not yet adults, pregnant women, prisoners.

About University Of Miami

The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.

Locations

Miami, Florida, United States

Patients applied

0 patients applied

Trial Officials

Victor H Hernandez, MD

Principal Investigator

University of Miami

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported